BioLight Israeli Life Sciences Investments Ltd. (BLGTY:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BioLight Israeli Life Sciences Investments Ltd. (BLGTY: OTCQX International) | BioLight Added to the TA-Biomed and the TA-BlueTech Indices on the TASE BioLight Added to the TA-Biomed and the TA-BlueTech Indices on the TASE

BioLight Added to the TA-Biomed and the TA-BlueTech Indices on the TASE

PR Newswire

TEL AVIV, Israel , June 16, 2014 /PRNewswire/ --

BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT) , a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that it has been notified by the Tel Aviv Stock Exchange that BioLight will be included in the Tel Aviv Biomed Index (TA-Biomed) and also in the Tel Aviv BlueTech index (TA- BlueTech), effective June 15, 2014 . The TA-Biomed tracks leading Biomed shares mainly based on the size of market capitalization and market float of the Biomed sector stocks that are traded on the Exchange. TA-BlueTech tracks leading shares mainly based on market capitalization of the Technology and Biomed sectors in the Exchange. Both indices serve as an underlying asset for financial vehicles, such as Index-Linked Certificates that are traded on the Exchange and indexed mutual funds.

"We are pleased to have our shares included in both the TA-Biomed and TA-BlueTech, the Tel Aviv Stock Exchange's most closely-tracked indices for Tech and Biomed companies shares," said Suzana Nahum-Zilberberg , BioLight's chief executive officer. "Joining the highly ranked companies on the Israeli Stock Exchange reflects BioLight's continued success and the recognition it receives from the capital markets."

About BioLight  

BioLight Life Sciences Investments invests in, manages and commercializes biomedical innovations grouped into "clusters" around defined medical conditions. Its two current clusters are in ophthalmology via 100% ownership of XLVision Sciences and in cancer diagnostics via a 29% controlling ownership of Micromedic (TASE: MCTC). XLVision technologies include IOPtiMate™, a laser-based noninvasive surgical treatment for glaucoma; TeaRx, a point-of-care dry-eye syndrome diagnostic test; and Eye-D™, a long-term controlled release drug-delivery implant platform. Micromedic diagnostic tests are designed to detect colorectal, cervical, breast, bladder, lung and other cancers. Leading key investors, holding about 45% of BioLight's shares, are Mr. Israel Makov , Chairman of Sun Pharmaceuticals, former CEO and President of Teva Pharmaceuticals and former Chairman of Given Imaging, Mr. Dilip Shanghvi , founder of Sun Pharmaceuticals, India's largest pharmaceutical company, and Mr. Dan Oren , founder and CEO of Dexcel Pharma, the second-largest pharmaceutical manufacturer in Israel .

For more information please visit the Company's website at www.bio-light.co.il .

CONTACTS:  

BioLight
Itai Bar-Natan , CFO ( itai@bio-light.co.il )
Tel: +972-73-2753400

LHA
Kim Sutton Golodetz ( kgolodetz@lhai.com )
+1-(212)-838-3777

Or

Bruce Voss ( bvoss@lhai.com )
+1-(310)-691-7100

SOURCE BioLight Life Sciences Investments Ltd

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Cloud Native Innovations at KubeDay Colombia!

Updated Category News Views 67

Join the Cloud Native Community at KubeDay Colombia KubeDay Colombia is geared towards tech enthusiasts of all backgrounds, offering a unique opportunity for cloud native speakers to connect with community members in Medellín. This gathering invites everyone interested in the advancing cloud native scene to learn, exchange ideas, and collaborate. Event Highlights and...

Continue Reading
Nektar Therapeutics to Showcase Innovations at Key Conferences

Updated Category News Views 154

Nektar Therapeutics to Showcase Innovations at Key Conferences Nektar Therapeutics (Nasdaq: NKTR) has recently made an exciting announcement regarding its participation in some significant upcoming investor conferences. This is a notable opportunity for the company to share insights into its leading-edge developments and innovative therapies aimed at addressing serious...

Continue Reading
Growth of Lab Automation Market to $11.31 Billion by 2031

Updated Category News Views 41

Understanding the Growth of Lab Automation and Its Future The lab automation industry is progressing quickly, with forecasts estimating it will reach an impressive $11.31 billion by 2031. This remarkable growth is largely due to rising investments in research and development in the pharmaceutical and biotechnology sectors. The market is expected to grow at a compound...

Continue Reading
Lightbridge Corporation Celebrates Partnership for Nuclear Fuel Advancements

Updated Category News Views 302

Lightbridge Corporation Applauds New Nuclear Fuel Initiative Lightbridge Corporation, an innovative company in advanced nuclear fuel technology, recently expressed its strong approval regarding the newly established Memorandum of Understanding (MOU) between the U.S. Nuclear Regulatory Commission (NRC) and the U.S. Department of Energy (DOE). This MOU aims to foster...

Continue Reading
UK's Autumn Budget Challenges and Market Reactions Explained

Updated Category News Views 181

Market Tempests and UK Budget Insights The recent week has been tumultuous for investors as various global economic factors triggered cautious sentiments all around. Despite some encouraging earnings from leading companies, notably the recent performance of Nvidia, the positive vibes were short-lived amidst growing trepidation about future conditions. Concerns regarding...

Continue Reading